Transamerica Financial Advisors, Inc. Amgen Inc Transaction History

Transamerica Financial Advisors, Inc.

$1.01 Billion
Q4 2024

A detailed history of Transamerica Financial Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 19 shares of AMGN stock, worth $5,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 20 5.0%

Holding current value

$5,591

Previous $7,000 28.57%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$258.78 - $328.31 $258 - $328	-1 Reduced 5.0%	19 $5,000
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $6,187 - $6,747	20 New	20 $7,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $6,721 - $8,114	25 New	25 $8,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $877 - $970	-4 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $198 - $227	1 Added 33.33%	4 $1,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $432 - $515	-2 Reduced 40.0%	3 $1,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $236,996 - $263,559	-1,010 Reduced 99.51%	5 $2,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $200,777 - $246,381	1,015 New	1,015 $240,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $144,511 - $173,154	-830 Closed	0 $0
Q2 2019 Aug 21, 2019	BUY	$166.7 - $195.41 $138,361 - $162,190	830 New	830 $153,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $75,061 - $84,610	-415 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $34,431 - $40,192	193 Added 86.94%	415 $81,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $40,207 - $45,329	217 Added 4340.0%	222 $46,000
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $830 - $932	5 New	5 $1,000

Others Institutions Holding AMGN

# of Institutions

3,161

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.

Account

Transamerica Financial Advisors, Inc. Amgen Inc Transaction History